Parkinson's Disease Pipeline Market H1 2018 Drug Profiles and Therapeutics Development
PUNE, India, June 29, 2018 /PRNewswire/ --
ReportsnReports.com adds latest Pharmaceutical and Healthcare disease pipeline guide Parkinson's Disease Pipeline Market Review, H1 2018, provides an overview of the Parkinson's Disease (Central Nervous System) pipeline landscape.
Parkinson's disease is a neurodegenerative disorder characterized by movement dysfunctions. It causes involuntary shaking, stiffness and impaired locomotory functions. Age, genetic factors, head trauma, environmental factors, hormonal changes, etc are predisposing factors for Parkinson's disease. Parkinson's disease results in abnormal functioning or death of neurons. The neurons are responsible for the synthesis of neurotransmitter dopamine which is further responsible for the transmission of signals. The effect on the neurons blocks effective neurotransmission and may lead to eventual decline in movement and coordination.
Browse complete report of Parkinson's Disease Pipeline Market with 19 company profiles, 881 no. of pages, 76 List of Tables and 11 List of Figures at http://www.reportsnreports.com/reports/1559910-parkinsons-disease-pipeline-review-h1-2018.html
The Pharmaceutical and Healthcare latest pipeline guide Parkinson's Disease Pipeline Market Review, H1 2018, provides comprehensive information on the therapeutics under development for Parkinson's Disease (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Parkinson's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Parkinson's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 1, 7, 44, 46, 3, 187, 56 and 11 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 46 and 12 molecules, respectively.
Order a Copy of Parkinson's Disease Pipeline Market Report at http://www.reportsnreports.com/purchase.aspx?name=1559910
Parkinson's Disease (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Parkinson's Disease Pipeline (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Parkinson's Disease (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Parkinson's Disease (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Parkinson's Disease (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Parkinson's Disease (Central Nervous System)
Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1559910
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Parkinson's Disease (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Parkinson's Disease (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Introduction
Parkinson's Disease - Overview
Parkinson's Disease - Therapeutics Development
Parkinson's Disease - Therapeutics Assessment
Parkinson's Disease - Companies Involved in Therapeutics Development
Parkinson's Disease - Drug Profiles
Parkinson's Disease - Dormant Projects
Parkinson's Disease - Discontinued Products
Parkinson's Disease - Product Development Milestones
Appendix
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. We provide 24/7 online and offline support to our customers.
Contact:
Hrishikesh Patwardhan
2nd Floor, Metropole,
Bund Garden Road,
Pune - 411001,
Maharashtra, India.
Tel: +1-888-391-5441
E-mail: [email protected]
Connect With Us on:
Facebook: https://www.facebook.com/pages/ReportsnReports/191441427571689
LinkedIn: http://www.linkedin.com/company/reportsnreports
Twitter: https: //twitter.com/marketsreports
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts
Pinterest: http://www.pinterest.com/comeonseo/reportsnreports/
RSS/Feeds: http://www.reportsnreports.com/feed/p-181-prof-research.xml
Share this article